Huxie Huaji Ointment Induced Apoptosis of Liver Cancer Cells In Vivo and In Vitro by Activating the Mitochondrial Pathway

• Published in: Evidence-based complementary and alternative medicine Vol. 2021; pp. 1 - 13
• Main Authors: Cai, Yuan, Du, Qing, Deng, Tian-Hao, Shen, Bing-Bing, Peng, Yan-Mei, Zeng, Pu-Hua, Yu, Song-Ren
• Format: Journal Article
• Language: English
• Published: New York Hindawi 15.07.2021; Hindawi Limited
• Subjects: Apoptosis; Bcl-2 protein; Cancer therapies; Caspase-3; Cell proliferation; Cell viability; Chemotherapy; Chinese medicine; Cytochrome c; Cytology; Detoxification; Hepatocellular carcinoma; Hepatocytes; Immunofluorescence; Immunohistochemistry; Laboratory animals; Liquid chromatography; Liver cancer; Lymphocytes B; Mammals; Mass spectroscopy; Metastasis; Mitochondria; Ointments; p53 Protein; Proteins; Proteolysis; Quality control; Quality of life; Radiation therapy; Signal transduction; Software; Tumor cells; Tumor suppressor genes; Western blotting; Xenografts; Beijing China; New York; United States > US; China
• DOI: 10.1155/2021/9922059
• ISSN: 1741-427X

Huxie Huaji (HXHJ) Ointment is a famous traditional Chinese medicinal prescription and is commonly used for the clinical treatment of hepatocellular carcinoma by boosting immunity and detoxification. However, the scientific evidence for the effect of HXHJ Ointment on hepatocellular carcinoma and the underlying molecular mechanism are lacking. The present study aimed to identify the effects of HXHJ Ointment on hepatocellular carcinoma in vitro and in vivo as well as investigating the mechanistic basis for the anticancer effect of HXHJ ointment. First, liquid chromatography-mass spectrometry was used to verify the composition of HXHJ Ointment and quality control. Second, in vitro, Cell Counting Kit (CCK8) cell viability assay and Hoechst 33342 staining assay were performed to explain the cell apoptosis. The protein levels of tumor suppressor protein (p53), B-cell lymphoma 2 gene (Bcl-2), cytochrome C (Cyt-C), and aspartate proteolytic enzyme-3 (caspase-3) were examined by immunofluorescence. Finally, in vivo, hematoxylin and eosin (H&E) staining was used to observe the pathological changes in hepatocellular carcinoma samples. Western blots and immunohistochemistry were used to detect the anticancer properties of HXHJ ointment. The results in vitro showed that 20% HXHJ Ointment serum could significantly inhibit HepG2 cell proliferation, increased tumor suppressor gene p53, downregulated antiapoptotic protein Bcl-2, promoted the release of mitochondrial Cyt-C, activated caspase-3, and induced HepG2 cell apoptosis. Furthermore, in vivo experiments showed that HXHJ Ointment could effectively inhibit tumor growth in nude mice xenotransplanted with HepG2 cells, changed the morphology of tumor cells, and regulated the expression of apoptosis-related protein pathway p53/Bcl-2/Cyt-C/caspase-3. HXHJ Ointment can significantly inhibit the development of hepatocellular carcinoma, and its mechanism may be related to the regulation of p53/Bcl-2/Cyt-C/caspase-3 signaling pathway to induce cell mitochondrial apoptosis.